Interestingly, we demonstrated that naringin can reduced insulin resistance and increase the mRNA expressions of SOD1, CAT, mTOR, and PGC-1α, while showing significantly decreased expressions of Atrogin-1 and MuRF-1 mRNA. The gene discussed is PPARGC1A; the disease is Insulin resistance.